TECTONIC THERAPEUTIC, INC. Increase (Decrease) in Other Operating Assets
TECTONIC THERAPEUTIC, INC. (TECX) reported Increase (Decrease) in Other Operating Assets of -$40.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-03-14
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for the quarter ending 2023-12-31 was -$40.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for the quarter ending 2023-03-31 was $0.00.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was -$1.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was -$12.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for fiscal 2023 was -$40.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for fiscal 2022 was -$34.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for fiscal 2021 was -$362.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other operating assets for fiscal 2020 was -$84.00K, a 134.85% decline from fiscal 2019.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$40.00K 10-K · filed 2024-03-14 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | -$1.00K derived: sum of 2 quarters · filed 2024-03-14 | -$13.00K derived: sum of 3 quarters · filed 2024-03-14 | -$23.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$13.00K derived: sum of 2 quarters · filed 2024-03-14 | -$23.00K derived: sum of 3 quarters · filed 2024-03-14 | -$34.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$22.00K derived: sum of 2 quarters · filed 2023-11-09 | -$33.00K 10-Q · filed 2023-11-09 | -$43.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$21.00K 10-Q · filed 2023-08-10 | -$31.00K derived: sum of 3 quarters · filed 2023-08-10 | -$40.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$11.00K 10-Q · filed 2023-05-11 | -$21.00K derived: sum of 2 quarters · filed 2023-05-11 | -$30.00K derived: sum of 3 quarters · filed 2023-05-11 | -$363.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$19.00K derived: sum of 2 quarters · filed 2023-03-23 | -$352.00K derived: sum of 3 quarters · filed 2023-03-23 | -$362.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$342.00K derived: sum of 2 quarters · filed 2022-11-08 | -$352.00K 10-Q · filed 2022-11-08 | -$276.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$343.00K 10-Q · filed 2022-08-09 | -$267.00K derived: sum of 3 quarters · filed 2022-08-09 | -$351.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$10.00K 10-Q · filed 2022-05-10 | $66.00K derived: sum of 2 quarters · filed 2022-05-10 | -$18.00K derived: sum of 3 quarters · filed 2022-05-10 | $225.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$8.00K derived: sum of 2 quarters · filed 2022-03-17 | $235.00K derived: sum of 3 quarters · filed 2022-03-17 | -$84.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | -$84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $159.00K derived: sum of 2 quarters · filed 2021-11-04 | -$160.00K 10-Q · filed 2021-11-04 | $68.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$76.00K 10-Q · filed 2021-08-05 | $152.00K derived: sum of 3 quarters · filed 2021-08-05 | $108.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$319.00K 10-Q · filed 2021-05-13 | -$91.00K derived: sum of 2 quarters · filed 2021-05-13 | -$135.00K derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $184.00K derived: sum of 2 quarters · filed 2021-03-18 | $241.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $13.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $57.00K 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | -$268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$185.00K derived: sum of 2 quarters · filed 2020-03-16 | -$191.00K derived: sum of 3 quarters · filed 2020-03-16 | $115.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $77.00K derived: sum of 2 quarters · filed 2019-11-07 | $383.00K 10-Q · filed 2019-11-07 | $460.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $300.00K 10-Q · filed 2019-08-08 | $377.00K derived: sum of 3 quarters · filed 2019-08-08 | $515.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $306.00K 10-Q · filed 2019-05-13 | $383.00K derived: sum of 2 quarters · filed 2019-05-13 | $521.00K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $215.00K derived: sum of 2 quarters · filed 2019-03-25 | $218.00K 10-K · filed 2019-03-25 | |
| 2017-09-30 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $141.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $3.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |